nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP1A2—chronic obstructive pulmonary disease	0.436	1	CbGaD
Praziquantel—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0523	0.13	CbGbCtD
Praziquantel—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0523	0.13	CbGbCtD
Praziquantel—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0411	0.102	CbGbCtD
Praziquantel—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0398	0.0992	CbGbCtD
Praziquantel—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0398	0.0992	CbGbCtD
Praziquantel—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0355	0.0884	CbGbCtD
Praziquantel—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0334	0.0832	CbGbCtD
Praziquantel—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0226	0.0562	CbGbCtD
Praziquantel—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.022	0.0548	CbGbCtD
Praziquantel—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0215	0.0536	CbGbCtD
Praziquantel—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0192	0.0478	CbGbCtD
Praziquantel—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0113	0.028	CbGbCtD
Praziquantel—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0106	0.0265	CbGbCtD
Praziquantel—Palonosetron—CYP1A2—chronic obstructive pulmonary disease	0.0044	1	CrCbGaD
Praziquantel—Bone disorder—Formoterol—chronic obstructive pulmonary disease	0.00156	0.0141	CcSEcCtD
Praziquantel—Bone disorder—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.0141	CcSEcCtD
Praziquantel—Bone disorder—Montelukast—chronic obstructive pulmonary disease	0.00153	0.0138	CcSEcCtD
Praziquantel—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.0131	CcSEcCtD
Praziquantel—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.00145	0.0131	CcSEcCtD
Praziquantel—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.0117	CcSEcCtD
Praziquantel—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.0114	CcSEcCtD
Praziquantel—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.0102	CcSEcCtD
Praziquantel—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.0099	CcSEcCtD
Praziquantel—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00986	CcSEcCtD
Praziquantel—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00934	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00928	CcSEcCtD
Praziquantel—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00923	CcSEcCtD
Praziquantel—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000973	0.00878	CcSEcCtD
Praziquantel—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000964	0.0087	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000904	0.00816	CcSEcCtD
Praziquantel—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000862	0.00779	CcSEcCtD
Praziquantel—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000859	0.00775	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000856	0.00773	CcSEcCtD
Praziquantel—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000855	0.00772	CcSEcCtD
Praziquantel—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000832	0.00751	CcSEcCtD
Praziquantel—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000817	0.00738	CcSEcCtD
Praziquantel—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000811	0.00733	CcSEcCtD
Praziquantel—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000793	0.00716	CcSEcCtD
Praziquantel—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000788	0.00712	CcSEcCtD
Praziquantel—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000784	0.00708	CcSEcCtD
Praziquantel—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000784	0.00708	CcSEcCtD
Praziquantel—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00698	CcSEcCtD
Praziquantel—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00673	CcSEcCtD
Praziquantel—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000731	0.0066	CcSEcCtD
Praziquantel—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000712	0.00643	CcSEcCtD
Praziquantel—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000702	0.00634	CcSEcCtD
Praziquantel—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000679	0.00613	CcSEcCtD
Praziquantel—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000658	0.00594	CcSEcCtD
Praziquantel—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000658	0.00594	CcSEcCtD
Praziquantel—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000656	0.00592	CcSEcCtD
Praziquantel—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000651	0.00588	CcSEcCtD
Praziquantel—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000649	0.00586	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000646	0.00584	CcSEcCtD
Praziquantel—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000644	0.00582	CcSEcCtD
Praziquantel—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00064	0.00578	CcSEcCtD
Praziquantel—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00064	0.00578	CcSEcCtD
Praziquantel—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00572	CcSEcCtD
Praziquantel—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00572	CcSEcCtD
Praziquantel—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000631	0.0057	CcSEcCtD
Praziquantel—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000631	0.00569	CcSEcCtD
Praziquantel—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000627	0.00566	CcSEcCtD
Praziquantel—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000625	0.00565	CcSEcCtD
Praziquantel—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000625	0.00564	CcSEcCtD
Praziquantel—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000621	0.00561	CcSEcCtD
Praziquantel—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00561	CcSEcCtD
Praziquantel—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000612	0.00552	CcSEcCtD
Praziquantel—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000606	0.00547	CcSEcCtD
Praziquantel—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00546	CcSEcCtD
Praziquantel—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.0054	CcSEcCtD
Praziquantel—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000589	0.00532	CcSEcCtD
Praziquantel—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000575	0.00519	CcSEcCtD
Praziquantel—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000572	0.00517	CcSEcCtD
Praziquantel—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000572	0.00517	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000568	0.00513	CcSEcCtD
Praziquantel—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00502	CcSEcCtD
Praziquantel—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00502	CcSEcCtD
Praziquantel—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000541	0.00488	CcSEcCtD
Praziquantel—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00488	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000539	0.00486	CcSEcCtD
Praziquantel—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000526	0.00475	CcSEcCtD
Praziquantel—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00474	CcSEcCtD
Praziquantel—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000525	0.00474	CcSEcCtD
Praziquantel—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000525	0.00474	CcSEcCtD
Praziquantel—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00473	CcSEcCtD
Praziquantel—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.00473	CcSEcCtD
Praziquantel—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.00472	CcSEcCtD
Praziquantel—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.00472	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00471	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00471	CcSEcCtD
Praziquantel—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00469	CcSEcCtD
Praziquantel—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00469	CcSEcCtD
Praziquantel—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000514	0.00465	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000511	0.00461	CcSEcCtD
Praziquantel—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00051	0.00461	CcSEcCtD
Praziquantel—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000496	0.00448	CcSEcCtD
Praziquantel—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000496	0.00448	CcSEcCtD
Praziquantel—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000494	0.00446	CcSEcCtD
Praziquantel—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.00446	CcSEcCtD
Praziquantel—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00445	CcSEcCtD
Praziquantel—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00442	CcSEcCtD
Praziquantel—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00442	CcSEcCtD
Praziquantel—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00442	CcSEcCtD
Praziquantel—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000487	0.0044	CcSEcCtD
Praziquantel—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000484	0.00437	CcSEcCtD
Praziquantel—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000479	0.00433	CcSEcCtD
Praziquantel—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000468	0.00423	CcSEcCtD
Praziquantel—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000466	0.00421	CcSEcCtD
Praziquantel—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00417	CcSEcCtD
Praziquantel—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00046	0.00415	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000459	0.00414	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000459	0.00414	CcSEcCtD
Praziquantel—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00409	CcSEcCtD
Praziquantel—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000453	0.00409	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000449	0.00406	CcSEcCtD
Praziquantel—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00404	CcSEcCtD
Praziquantel—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00404	CcSEcCtD
Praziquantel—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000441	0.00399	CcSEcCtD
Praziquantel—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000438	0.00396	CcSEcCtD
Praziquantel—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00395	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00393	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00393	CcSEcCtD
Praziquantel—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.00392	CcSEcCtD
Praziquantel—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000434	0.00392	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00391	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000426	0.00384	CcSEcCtD
Praziquantel—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000425	0.00384	CcSEcCtD
Praziquantel—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00382	CcSEcCtD
Praziquantel—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000421	0.0038	CcSEcCtD
Praziquantel—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00377	CcSEcCtD
Praziquantel—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00376	CcSEcCtD
Praziquantel—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.00375	CcSEcCtD
Praziquantel—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000415	0.00375	CcSEcCtD
Praziquantel—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000414	0.00374	CcSEcCtD
Praziquantel—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00373	CcSEcCtD
Praziquantel—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.00373	CcSEcCtD
Praziquantel—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.00372	CcSEcCtD
Praziquantel—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000412	0.00372	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.00371	CcSEcCtD
Praziquantel—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.0037	CcSEcCtD
Praziquantel—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00364	CcSEcCtD
Praziquantel—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00361	CcSEcCtD
Praziquantel—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00361	CcSEcCtD
Praziquantel—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00359	CcSEcCtD
Praziquantel—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00359	CcSEcCtD
Praziquantel—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00359	CcSEcCtD
Praziquantel—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00359	CcSEcCtD
Praziquantel—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000397	0.00358	CcSEcCtD
Praziquantel—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.00355	CcSEcCtD
Praziquantel—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.00355	CcSEcCtD
Praziquantel—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000393	0.00355	CcSEcCtD
Praziquantel—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000392	0.00354	CcSEcCtD
Praziquantel—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00354	CcSEcCtD
Praziquantel—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000391	0.00353	CcSEcCtD
Praziquantel—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.00353	CcSEcCtD
Praziquantel—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00352	CcSEcCtD
Praziquantel—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00352	CcSEcCtD
Praziquantel—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.00351	CcSEcCtD
Praziquantel—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00341	CcSEcCtD
Praziquantel—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00339	CcSEcCtD
Praziquantel—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00339	CcSEcCtD
Praziquantel—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00335	CcSEcCtD
Praziquantel—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00335	CcSEcCtD
Praziquantel—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000371	0.00335	CcSEcCtD
Praziquantel—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000363	0.00328	CcSEcCtD
Praziquantel—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00326	CcSEcCtD
Praziquantel—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00326	CcSEcCtD
Praziquantel—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00322	CcSEcCtD
Praziquantel—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00322	CcSEcCtD
Praziquantel—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000354	0.0032	CcSEcCtD
Praziquantel—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00316	CcSEcCtD
Praziquantel—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000349	0.00315	CcSEcCtD
Praziquantel—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00311	CcSEcCtD
Praziquantel—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00311	CcSEcCtD
Praziquantel—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.0031	CcSEcCtD
Praziquantel—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00308	CcSEcCtD
Praziquantel—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00305	CcSEcCtD
Praziquantel—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00304	CcSEcCtD
Praziquantel—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00301	CcSEcCtD
Praziquantel—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00301	CcSEcCtD
Praziquantel—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00294	CcSEcCtD
Praziquantel—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00294	CcSEcCtD
Praziquantel—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00289	CcSEcCtD
Praziquantel—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00289	CcSEcCtD
Praziquantel—Rash—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00287	CcSEcCtD
Praziquantel—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00287	CcSEcCtD
Praziquantel—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00286	CcSEcCtD
Praziquantel—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00286	CcSEcCtD
Praziquantel—Headache—Formoterol—chronic obstructive pulmonary disease	0.000315	0.00285	CcSEcCtD
Praziquantel—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.00285	CcSEcCtD
Praziquantel—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00284	CcSEcCtD
Praziquantel—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00283	CcSEcCtD
Praziquantel—Rash—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00281	CcSEcCtD
Praziquantel—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00281	CcSEcCtD
Praziquantel—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.0028	CcSEcCtD
Praziquantel—Headache—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00279	CcSEcCtD
Praziquantel—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00273	CcSEcCtD
Praziquantel—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000301	0.00272	CcSEcCtD
Praziquantel—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.00271	CcSEcCtD
Praziquantel—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00271	CcSEcCtD
Praziquantel—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.0027	CcSEcCtD
Praziquantel—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000299	0.0027	CcSEcCtD
Praziquantel—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.0027	CcSEcCtD
Praziquantel—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00269	CcSEcCtD
Praziquantel—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00265	CcSEcCtD
Praziquantel—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.00261	CcSEcCtD
Praziquantel—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00256	CcSEcCtD
Praziquantel—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00255	CcSEcCtD
Praziquantel—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000281	0.00254	CcSEcCtD
Praziquantel—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00564	CbGpPWpGaD
Praziquantel—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000265	0.00558	CbGpPWpGaD
Praziquantel—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000261	0.00551	CbGpPWpGaD
Praziquantel—CYP3A43—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000259	0.00546	CbGpPWpGaD
Praziquantel—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000256	0.0054	CbGpPWpGaD
Praziquantel—CYP3A43—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000256	0.00539	CbGpPWpGaD
Praziquantel—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000254	0.00536	CbGpPWpGaD
Praziquantel—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00227	CcSEcCtD
Praziquantel—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000251	0.0053	CbGpPWpGaD
Praziquantel—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00225	CcSEcCtD
Praziquantel—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000245	0.00517	CbGpPWpGaD
Praziquantel—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000241	0.00508	CbGpPWpGaD
Praziquantel—CYP3A43—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000238	0.00502	CbGpPWpGaD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000236	0.00497	CbGpPWpGaD
Praziquantel—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000235	0.00496	CbGpPWpGaD
Praziquantel—CYP3A43—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000235	0.00495	CbGpPWpGaD
Praziquantel—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.00477	CbGpPWpGaD
Praziquantel—CYP3A43—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000226	0.00476	CbGpPWpGaD
Praziquantel—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000225	0.00475	CbGpPWpGaD
Praziquantel—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00203	CcSEcCtD
Praziquantel—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.00203	CcSEcCtD
Praziquantel—CYP3A43—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000223	0.0047	CbGpPWpGaD
Praziquantel—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00467	CbGpPWpGaD
Praziquantel—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00198	CcSEcCtD
Praziquantel—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00197	CcSEcCtD
Praziquantel—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00196	CcSEcCtD
Praziquantel—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000215	0.00453	CbGpPWpGaD
Praziquantel—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00449	CbGpPWpGaD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.00445	CbGpPWpGaD
Praziquantel—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.00445	CbGpPWpGaD
Praziquantel—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00021	0.0019	CcSEcCtD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00443	CbGpPWpGaD
Praziquantel—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00439	CbGpPWpGaD
Praziquantel—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00437	CbGpPWpGaD
Praziquantel—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000207	0.00437	CbGpPWpGaD
Praziquantel—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00187	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00185	CcSEcCtD
Praziquantel—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00431	CbGpPWpGaD
Praziquantel—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00184	CcSEcCtD
Praziquantel—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00181	CcSEcCtD
Praziquantel—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000196	0.00414	CbGpPWpGaD
Praziquantel—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00175	CcSEcCtD
Praziquantel—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.00409	CbGpPWpGaD
Praziquantel—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00174	CcSEcCtD
Praziquantel—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00171	CcSEcCtD
Praziquantel—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000188	0.00396	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000186	0.00393	CbGpPWpGaD
Praziquantel—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00392	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—APIP—chronic obstructive pulmonary disease	0.000182	0.00383	CbGpPWpGaD
Praziquantel—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00163	CcSEcCtD
Praziquantel—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00163	CcSEcCtD
Praziquantel—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000176	0.0037	CbGpPWpGaD
Praziquantel—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00156	CcSEcCtD
Praziquantel—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00155	CcSEcCtD
Praziquantel—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00155	CcSEcCtD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.00361	CbGpPWpGaD
Praziquantel—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.0036	CbGpPWpGaD
Praziquantel—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00154	CcSEcCtD
Praziquantel—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00154	CcSEcCtD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00359	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000166	0.0035	CbGpPWpGaD
Praziquantel—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.00347	CbGpPWpGaD
Praziquantel—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.00347	CbGpPWpGaD
Praziquantel—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00147	CcSEcCtD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000162	0.00342	CbGpPWpGaD
Praziquantel—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00146	CcSEcCtD
Praziquantel—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00146	CcSEcCtD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.00338	CbGpPWpGaD
Praziquantel—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00142	CcSEcCtD
Praziquantel—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00141	CcSEcCtD
Praziquantel—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00141	CcSEcCtD
Praziquantel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00324	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000153	0.00322	CbGpPWpGaD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000153	0.00322	CbGpPWpGaD
Praziquantel—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00318	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000151	0.00318	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00315	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000149	0.00314	CbGpPWpGaD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00311	CbGpPWpGaD
Praziquantel—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00132	CcSEcCtD
Praziquantel—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00128	CcSEcCtD
Praziquantel—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00127	CcSEcCtD
Praziquantel—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00288	CbGpPWpGaD
Praziquantel—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00122	CcSEcCtD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00278	CbGpPWpGaD
Praziquantel—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00118	CcSEcCtD
Praziquantel—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000129	0.00273	CbGpPWpGaD
Praziquantel—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00114	CcSEcCtD
Praziquantel—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00264	CbGpPWpGaD
Praziquantel—Rash—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00113	CcSEcCtD
Praziquantel—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00113	CcSEcCtD
Praziquantel—Headache—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00112	CcSEcCtD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00261	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.0026	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00255	CbGpPWpGaD
Praziquantel—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00255	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00012	0.00254	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00249	CbGpPWpGaD
Praziquantel—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00106	CcSEcCtD
Praziquantel—CYP3A43—Metabolism—GC—chronic obstructive pulmonary disease	0.000117	0.00247	CbGpPWpGaD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00246	CbGpPWpGaD
Praziquantel—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.0024	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.0024	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.0024	CbGpPWpGaD
Praziquantel—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00236	CbGpPWpGaD
Praziquantel—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000111	0.00234	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000109	0.0023	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000109	0.00229	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00229	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000108	0.00227	CbGpPWpGaD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00226	CbGpPWpGaD
Praziquantel—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00224	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000104	0.0022	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000103	0.00217	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.99e-05	0.00211	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.77e-05	0.00206	CbGpPWpGaD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.64e-05	0.00203	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.59e-05	0.00202	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.57e-05	0.00202	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.46e-05	0.00199	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.2e-05	0.00194	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.09e-05	0.00192	CbGpPWpGaD
Praziquantel—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.07e-05	0.00191	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.05e-05	0.00191	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.97e-05	0.00189	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.92e-05	0.00188	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.8e-05	0.00186	CbGpPWpGaD
Praziquantel—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.78e-05	0.00185	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.42e-05	0.00177	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.32e-05	0.00175	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.92e-05	0.00167	CbGpPWpGaD
Praziquantel—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.77e-05	0.00164	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.74e-05	0.00163	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.65e-05	0.00161	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.55e-05	0.00159	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.45e-05	0.00157	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.44e-05	0.00157	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	7.32e-05	0.00154	CbGpPWpGaD
Praziquantel—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	7.14e-05	0.00151	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.1e-05	0.0015	CbGpPWpGaD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7e-05	0.00148	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.99e-05	0.00147	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.93e-05	0.00146	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.9e-05	0.00145	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.84e-05	0.00144	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.57e-05	0.00139	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.56e-05	0.00138	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.48e-05	0.00137	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.48e-05	0.00137	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.00136	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.39e-05	0.00135	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.34e-05	0.00134	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GCLC—chronic obstructive pulmonary disease	6.32e-05	0.00133	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.29e-05	0.00133	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.92e-05	0.00125	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.83e-05	0.00123	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CTGF—chronic obstructive pulmonary disease	5.77e-05	0.00122	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.75e-05	0.00121	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.75e-05	0.00121	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.37e-05	0.00113	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.36e-05	0.00113	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.33e-05	0.00112	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.31e-05	0.00112	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.29e-05	0.00112	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.29e-05	0.00112	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.29e-05	0.00111	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.08e-05	0.00107	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.06e-05	0.00107	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.01e-05	0.00106	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5e-05	0.00105	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.93e-05	0.00104	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.89e-05	0.00103	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.86e-05	0.00103	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.85e-05	0.00102	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.79e-05	0.00101	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.79e-05	0.00101	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	4.71e-05	0.000994	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.67e-05	0.000986	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.61e-05	0.000972	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.61e-05	0.000972	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.57e-05	0.000963	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.57e-05	0.000963	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.55e-05	0.000958	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.48e-05	0.000945	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.43e-05	0.000935	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.38e-05	0.000924	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.37e-05	0.000922	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.21e-05	0.000887	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.18e-05	0.000881	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.15e-05	0.000875	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.12e-05	0.000869	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.09e-05	0.000862	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.07e-05	0.000859	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.96e-05	0.000835	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.91e-05	0.000824	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.86e-05	0.000814	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.76e-05	0.000793	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.51e-05	0.00074	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.5e-05	0.000739	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.46e-05	0.00073	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.41e-05	0.000719	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.22e-05	0.00068	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.19e-05	0.000672	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.00067	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.17e-05	0.000668	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.06e-05	0.000644	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.01e-05	0.000636	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.92e-05	0.000615	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.71e-05	0.000571	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.69e-05	0.000566	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.63e-05	0.000556	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ALB—chronic obstructive pulmonary disease	2.62e-05	0.000553	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.58e-05	0.000543	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.55e-05	0.000537	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—NOS3—chronic obstructive pulmonary disease	2.51e-05	0.000529	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.49e-05	0.000525	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.46e-05	0.000518	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.45e-05	0.000516	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.42e-05	0.000511	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.00049	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000479	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.25e-05	0.000475	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000451	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.11e-05	0.000445	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.05e-05	0.000433	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.95e-05	0.000411	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.91e-05	0.000402	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.86e-05	0.000393	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.84e-05	0.000388	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.79e-05	0.000376	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000371	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.000354	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.64e-05	0.000346	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.63e-05	0.000343	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.58e-05	0.000334	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000328	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.55e-05	0.000326	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000321	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.47e-05	0.000311	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.44e-05	0.000303	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.42e-05	0.0003	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.33e-05	0.00028	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.32e-05	0.000279	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.31e-05	0.000276	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.3e-05	0.000274	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000272	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.27e-05	0.000268	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.000252	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.000252	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.19e-05	0.00025	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.000237	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000236	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000234	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	0.000232	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000223	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000218	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000213	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000213	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.98e-06	0.00021	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.84e-06	0.000207	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.18e-06	0.000193	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.17e-06	0.000193	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.05e-06	0.000191	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.69e-06	0.000183	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.65e-06	0.000183	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.56e-06	0.00018	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.43e-06	0.000178	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.99e-06	0.000169	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.81e-06	0.000165	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.77e-06	0.000164	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.67e-06	0.000162	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.64e-06	0.000161	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.31e-06	0.000154	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.19e-06	0.000152	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.14e-06	0.000151	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.77e-06	0.000143	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6e-06	0.000127	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.92e-06	0.000125	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.91e-06	0.000125	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.65e-06	0.000119	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.51e-06	0.000116	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.43e-06	0.000115	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.23e-06	0.00011	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.2e-06	0.00011	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.6e-06	9.71e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.4e-06	9.28e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.55e-06	7.49e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.4e-06	7.17e-05	CbGpPWpGaD
